▶ 調査レポート

メチルフェニデートのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Methylphenidate Market Insights and Forecast to 2028

Global Methylphenidate Market Insights and Forecast to 2028「メチルフェニデートのグローバル市場インサイト・予測(~2028年)」(市場規模、市場予測)調査レポートです。• レポートコード:QY2203B06639
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、88ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥651,700 (USD4,900)▷ お問い合わせ
  Multi User¥977,550 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,303,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のメチルフェニデートの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にメチルフェニデートの世界市場のxxx%を占める「錠」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「注意欠陥多動性障害」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のメチルフェニデートの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのメチルフェニデート市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのメチルフェニデート市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

メチルフェニデートのグローバル主要メーカーには、Pfizer、Teva、Novartis、Sandoz、GSKなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

メチルフェニデート市場は、種類と用途によって区分されます。世界のメチルフェニデート市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
錠、カプセル、その他

【用途別セグメント】
注意欠陥多動性障害、ナルコレプシー、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- メチルフェニデート製品概要
- 種類別市場(錠、カプセル、その他)
- 用途別市場(注意欠陥多動性障害、ナルコレプシー、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のメチルフェニデート販売量予測2017-2028
- 世界のメチルフェニデート売上予測2017-2028
- メチルフェニデートの地域別販売量
- メチルフェニデートの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別メチルフェニデート販売量
- 主要メーカー別メチルフェニデート売上
- 主要メーカー別メチルフェニデート価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(錠、カプセル、その他)
- メチルフェニデートの種類別販売量
- メチルフェニデートの種類別売上
- メチルフェニデートの種類別価格
・用途別市場規模(注意欠陥多動性障害、ナルコレプシー、その他)
- メチルフェニデートの用途別販売量
- メチルフェニデートの用途別売上
- メチルフェニデートの用途別価格
・北米市場
- 北米のメチルフェニデート市場規模(種類別、用途別)
- 主要国別のメチルフェニデート市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのメチルフェニデート市場規模(種類別、用途別)
- 主要国別のメチルフェニデート市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のメチルフェニデート市場規模(種類別、用途別)
- 主要国別のメチルフェニデート市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のメチルフェニデート市場規模(種類別、用途別)
- 主要国別のメチルフェニデート市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのメチルフェニデート市場規模(種類別、用途別)
- 主要国別のメチルフェニデート市場規模(トルコ、サウジアラビア)
・企業情報
Pfizer、Teva、Novartis、Sandoz、GSK
・産業チェーン及び販売チャネル分析
- メチルフェニデートの産業チェーン分析
- メチルフェニデートの原材料
- メチルフェニデートの生産プロセス
- メチルフェニデートの販売及びマーケティング
- メチルフェニデートの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- メチルフェニデートの産業動向
- メチルフェニデートのマーケットドライバー
- メチルフェニデートの課題
- メチルフェニデートの阻害要因
・主な調査結果

Market Analysis and Insights: Global Methylphenidate Market
Due to the COVID-19 pandemic, the global Methylphenidate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tablet accounting for % of the Methylphenidate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Attention deficit hyperactivity disorder segment is altered to an % CAGR throughout this forecast period.
China Methylphenidate market size is valued at US$ million in 2021, while the US and Europe Methylphenidate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Methylphenidate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Methylphenidate include Pfizer, Teva, Novartis, Sandoz and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Methylphenidate Scope and Segment
Methylphenidate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Methylphenidate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Capsule
Others
Segment by Application
Attention deficit hyperactivity disorder
Narcolepsy
Other
By Company
Pfizer
Teva
Novartis
Sandoz
GSK
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Methylphenidate Product Introduction
1.2 Market by Type
1.2.1 Global Methylphenidate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Others
1.3 Market by Application
1.3.1 Global Methylphenidate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Attention deficit hyperactivity disorder
1.3.3 Narcolepsy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Methylphenidate Sales Estimates and Forecasts 2017-2028
2.2 Global Methylphenidate Revenue Estimates and Forecasts 2017-2028
2.3 Global Methylphenidate Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Methylphenidate Sales by Region
2.4.1 Global Methylphenidate Sales by Region (2017-2022)
2.4.2 Global Sales Methylphenidate by Region (2023-2028)
2.5 Global Methylphenidate Revenue by Region
2.5.1 Global Methylphenidate Revenue by Region (2017-2022)
2.5.2 Global Methylphenidate Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Methylphenidate Sales by Manufacturers
3.1.1 Global Top Methylphenidate Manufacturers by Sales (2017-2022)
3.1.2 Global Methylphenidate Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Methylphenidate in 2021
3.2 Global Methylphenidate Revenue by Manufacturers
3.2.1 Global Methylphenidate Revenue by Manufacturers (2017-2022)
3.2.2 Global Methylphenidate Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Methylphenidate Revenue in 2021
3.3 Global Methylphenidate Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Methylphenidate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Methylphenidate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Methylphenidate Sales by Type
4.1.1 Global Methylphenidate Historical Sales by Type (2017-2022)
4.1.2 Global Methylphenidate Forecasted Sales by Type (2023-2028)
4.1.3 Global Methylphenidate Sales Market Share by Type (2017-2028)
4.2 Global Methylphenidate Revenue by Type
4.2.1 Global Methylphenidate Historical Revenue by Type (2017-2022)
4.2.2 Global Methylphenidate Forecasted Revenue by Type (2023-2028)
4.2.3 Global Methylphenidate Revenue Market Share by Type (2017-2028)
4.3 Global Methylphenidate Price by Type
4.3.1 Global Methylphenidate Price by Type (2017-2022)
4.3.2 Global Methylphenidate Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Methylphenidate Sales by Application
5.1.1 Global Methylphenidate Historical Sales by Application (2017-2022)
5.1.2 Global Methylphenidate Forecasted Sales by Application (2023-2028)
5.1.3 Global Methylphenidate Sales Market Share by Application (2017-2028)
5.2 Global Methylphenidate Revenue by Application
5.2.1 Global Methylphenidate Historical Revenue by Application (2017-2022)
5.2.2 Global Methylphenidate Forecasted Revenue by Application (2023-2028)
5.2.3 Global Methylphenidate Revenue Market Share by Application (2017-2028)
5.3 Global Methylphenidate Price by Application
5.3.1 Global Methylphenidate Price by Application (2017-2022)
5.3.2 Global Methylphenidate Price Forecast by Application (2023-2028)
6 North America
6.1 North America Methylphenidate Market Size by Type
6.1.1 North America Methylphenidate Sales by Type (2017-2028)
6.1.2 North America Methylphenidate Revenue by Type (2017-2028)
6.2 North America Methylphenidate Market Size by Application
6.2.1 North America Methylphenidate Sales by Application (2017-2028)
6.2.2 North America Methylphenidate Revenue by Application (2017-2028)
6.3 North America Methylphenidate Market Size by Country
6.3.1 North America Methylphenidate Sales by Country (2017-2028)
6.3.2 North America Methylphenidate Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Methylphenidate Market Size by Type
7.1.1 Europe Methylphenidate Sales by Type (2017-2028)
7.1.2 Europe Methylphenidate Revenue by Type (2017-2028)
7.2 Europe Methylphenidate Market Size by Application
7.2.1 Europe Methylphenidate Sales by Application (2017-2028)
7.2.2 Europe Methylphenidate Revenue by Application (2017-2028)
7.3 Europe Methylphenidate Market Size by Country
7.3.1 Europe Methylphenidate Sales by Country (2017-2028)
7.3.2 Europe Methylphenidate Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Methylphenidate Market Size by Type
8.1.1 Asia Pacific Methylphenidate Sales by Type (2017-2028)
8.1.2 Asia Pacific Methylphenidate Revenue by Type (2017-2028)
8.2 Asia Pacific Methylphenidate Market Size by Application
8.2.1 Asia Pacific Methylphenidate Sales by Application (2017-2028)
8.2.2 Asia Pacific Methylphenidate Revenue by Application (2017-2028)
8.3 Asia Pacific Methylphenidate Market Size by Region
8.3.1 Asia Pacific Methylphenidate Sales by Region (2017-2028)
8.3.2 Asia Pacific Methylphenidate Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Methylphenidate Market Size by Type
9.1.1 Latin America Methylphenidate Sales by Type (2017-2028)
9.1.2 Latin America Methylphenidate Revenue by Type (2017-2028)
9.2 Latin America Methylphenidate Market Size by Application
9.2.1 Latin America Methylphenidate Sales by Application (2017-2028)
9.2.2 Latin America Methylphenidate Revenue by Application (2017-2028)
9.3 Latin America Methylphenidate Market Size by Country
9.3.1 Latin America Methylphenidate Sales by Country (2017-2028)
9.3.2 Latin America Methylphenidate Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Methylphenidate Market Size by Type
10.1.1 Middle East and Africa Methylphenidate Sales by Type (2017-2028)
10.1.2 Middle East and Africa Methylphenidate Revenue by Type (2017-2028)
10.2 Middle East and Africa Methylphenidate Market Size by Application
10.2.1 Middle East and Africa Methylphenidate Sales by Application (2017-2028)
10.2.2 Middle East and Africa Methylphenidate Revenue by Application (2017-2028)
10.3 Middle East and Africa Methylphenidate Market Size by Country
10.3.1 Middle East and Africa Methylphenidate Sales by Country (2017-2028)
10.3.2 Middle East and Africa Methylphenidate Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Methylphenidate Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Methylphenidate Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Methylphenidate Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Methylphenidate Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sandoz Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sandoz Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Methylphenidate Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Methylphenidate Industry Chain Analysis
12.2 Methylphenidate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Methylphenidate Production Mode & Process
12.4 Methylphenidate Sales and Marketing
12.4.1 Methylphenidate Sales Channels
12.4.2 Methylphenidate Distributors
12.5 Methylphenidate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Methylphenidate Industry Trends
13.2 Methylphenidate Market Drivers
13.3 Methylphenidate Market Challenges
13.4 Methylphenidate Market Restraints
14 Key Findings in The Global Methylphenidate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Methylphenidate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Others
Table 5. Global Methylphenidate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Methylphenidate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Methylphenidate Sales by Region (2017-2022) & (K MT)
Table 8. Global Methylphenidate Sales Market Share by Region (2017-2022)
Table 9. Global Methylphenidate Sales by Region (2023-2028) & (K MT)
Table 10. Global Methylphenidate Sales Market Share by Region (2023-2028)
Table 11. Global Methylphenidate Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Methylphenidate Revenue Market Share by Region (2017-2022)
Table 13. Global Methylphenidate Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Methylphenidate Revenue Market Share by Region (2023-2028)
Table 15. Global Methylphenidate Sales by Manufacturers (2017-2022) & (K MT)
Table 16. Global Methylphenidate Sales Share by Manufacturers (2017-2022)
Table 17. Global Methylphenidate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Methylphenidate Revenue Share by Manufacturers (2017-2022)
Table 19. Methylphenidate Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Methylphenidate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Methylphenidate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate as of 2021)
Table 22. Methylphenidate Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Methylphenidate Product Offered
Table 24. Date of Manufacturers Enter into Methylphenidate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 27. Global Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 28. Global Methylphenidate Sales Share by Type (2017-2022)
Table 29. Global Methylphenidate Sales Share by Type (2023-2028)
Table 30. Global Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Methylphenidate Revenue Share by Type (2017-2022)
Table 33. Global Methylphenidate Revenue Share by Type (2023-2028)
Table 34. Methylphenidate Price by Type (2017-2022) & (USD/MT)
Table 35. Global Methylphenidate Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 37. Global Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 38. Global Methylphenidate Sales Share by Application (2017-2022)
Table 39. Global Methylphenidate Sales Share by Application (2023-2028)
Table 40. Global Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Methylphenidate Revenue Share by Application (2017-2022)
Table 43. Global Methylphenidate Revenue Share by Application (2023-2028)
Table 44. Methylphenidate Price by Application (2017-2022) & (USD/MT)
Table 45. Global Methylphenidate Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 47. North America Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 48. North America Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 51. North America Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 52. North America Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 55. North America Methylphenidate Sales by Country (2023-2028) & (K MT)
Table 56. North America Methylphenidate Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Methylphenidate Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 59. Europe Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 60. Europe Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 63. Europe Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 64. Europe Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 67. Europe Methylphenidate Sales by Country (2023-2028) & (K MT)
Table 68. Europe Methylphenidate Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Methylphenidate Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 71. Asia Pacific Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 72. Asia Pacific Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 75. Asia Pacific Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 76. Asia Pacific Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Methylphenidate Sales by Region (2017-2022) & (K MT)
Table 79. Asia Pacific Methylphenidate Sales by Region (2023-2028) & (K MT)
Table 80. Asia Pacific Methylphenidate Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Methylphenidate Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 83. Latin America Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 84. Latin America Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 87. Latin America Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 88. Latin America Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 91. Latin America Methylphenidate Sales by Country (2023-2028) & (K MT)
Table 92. Latin America Methylphenidate Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Methylphenidate Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 95. Middle East and Africa Methylphenidate Sales by Type (2023-2028) & (K MT)
Table 96. Middle East and Africa Methylphenidate Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Methylphenidate Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 99. Middle East and Africa Methylphenidate Sales by Application (2023-2028) & (K MT)
Table 100. Middle East and Africa Methylphenidate Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Methylphenidate Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 103. Middle East and Africa Methylphenidate Sales by Country (2023-2028) & (K MT)
Table 104. Middle East and Africa Methylphenidate Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Methylphenidate Revenue by Country (2023-2028) & (US$ Million)
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. Pfizer Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer Recent Developments
Table 111. Teva Corporation Information
Table 112. Teva Description and Major Businesses
Table 113. Teva Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Teva Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Teva Recent Developments
Table 116. Novartis Corporation Information
Table 117. Novartis Description and Major Businesses
Table 118. Novartis Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. Novartis Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Novartis Recent Developments
Table 121. Sandoz Corporation Information
Table 122. Sandoz Description and Major Businesses
Table 123. Sandoz Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Sandoz Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sandoz Recent Developments
Table 126. GSK Corporation Information
Table 127. GSK Description and Major Businesses
Table 128. GSK Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 129. GSK Methylphenidate Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. GSK Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Methylphenidate Distributors List
Table 134. Methylphenidate Customers List
Table 135. Methylphenidate Market Trends
Table 136. Methylphenidate Market Drivers
Table 137. Methylphenidate Market Challenges
Table 138. Methylphenidate Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Methylphenidate Product Picture
Figure 3. Global Methylphenidate Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Others Product Picture
Figure 6. Global Methylphenidate Market Share by Application in 2021 & 2028
Figure 7. Attention deficit hyperactivity disorder
Figure 8. Narcolepsy
Figure 9. Other
Figure 10. Methylphenidate Report Years Considered
Figure 11. Global Methylphenidate Sales 2017-2028 (K MT)
Figure 12. Global Methylphenidate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Methylphenidate Revenue 2017-2028 (US$ Million)
Figure 14. Global Methylphenidate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Methylphenidate Sales Market Share by Region (2017-2022)
Figure 16. Global Methylphenidate Sales Market Share by Region (2023-2028)
Figure 17. North America Methylphenidate Sales YoY (2017-2028) & (K MT)
Figure 18. North America Methylphenidate Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Methylphenidate Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Methylphenidate Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Methylphenidate Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Methylphenidate Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Methylphenidate Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Methylphenidate Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Methylphenidate Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Methylphenidate Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Methylphenidate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Methylphenidate in the World: Market Share by Methylphenidate Revenue in 2021
Figure 29. Global Methylphenidate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Methylphenidate Sales Market Share by Type (2017-2028)
Figure 31. Global Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 32. Global Methylphenidate Sales Market Share by Application (2017-2028)
Figure 33. Global Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 34. North America Methylphenidate Sales Market Share by Type (2017-2028)
Figure 35. North America Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 36. North America Methylphenidate Sales Market Share by Application (2017-2028)
Figure 37. North America Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 38. North America Methylphenidate Sales Share by Country (2017-2028)
Figure 39. North America Methylphenidate Revenue Share by Country (2017-2028)
Figure 40. U.S. Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Methylphenidate Sales Market Share by Type (2017-2028)
Figure 43. Europe Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 44. Europe Methylphenidate Sales Market Share by Application (2017-2028)
Figure 45. Europe Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 46. Europe Methylphenidate Sales Share by Country (2017-2028)
Figure 47. Europe Methylphenidate Revenue Share by Country (2017-2028)
Figure 48. Germany Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 49. France Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Methylphenidate Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Methylphenidate Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Methylphenidate Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Methylphenidate Revenue Share by Region (2017-2028)
Figure 59. China Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 62. India Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Methylphenidate Sales Market Share by Type (2017-2028)
Figure 69. Latin America Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Methylphenidate Sales Market Share by Application (2017-2028)
Figure 71. Latin America Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Methylphenidate Sales Share by Country (2017-2028)
Figure 73. Latin America Methylphenidate Revenue Share by Country (2017-2028)
Figure 74. Mexico Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Methylphenidate Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Methylphenidate Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Methylphenidate Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Methylphenidate Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Methylphenidate Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Methylphenidate Revenue Share by Country (2017-2028)
Figure 83. Turkey Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Methylphenidate Revenue (2017-2028) & (US$ Million)
Figure 86. Methylphenidate Value Chain
Figure 87. Methylphenidate Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed